Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 55
Filtrer
1.
J Clin Microbiol ; 62(6): e0010324, 2024 Jun 12.
Article de Anglais | MEDLINE | ID: mdl-38785446

RÉSUMÉ

The monkeypox virus (MPXV) outbreak, primarily endemic to Africa, has spread globally, with Brazil reporting the second-highest number of cases. The emergence of MPXV in non-endemic areas has raised concerns, particularly due to the co-circulation of other exanthematous viruses such as varicella-zoster virus (VZV) and molluscum contagiosum virus (MOCV). To perform an accurate differential diagnosis of MPXV during the ongoing outbreak in Minas Gerais, Brazil, a 5PLEX qPCR assay targeting orthopoxviruses (OPV), VZV, and MOCV was used to retrospectively analyze all clinical samples that tested negative for MPXV in the initial screening conducted at Funed. In summary, our study analyzed 1,175 clinical samples received from patients suspected of MPXV infection and found a positivity rate of 33.8% (397 samples) for MPXV using the non-variola qPCR assay. Testing the 778 MPXV-negative clinical samples using the 5PLEX qPCR assay revealed that 174 clinical samples (22.36%) tested positive for VZV. MOCV DNA was detected in 13 and other OPV in 3 clinical samples. The sequencing of randomly selected amplified clinical samples confirmed the initial molecular diagnosis. Analysis of patient profiles revealed a significant difference in the median age between groups testing positive for MPXV and VZV and a male predominance in MPXV cases. The geographic distribution of positive cases was concentrated in the most populous mesoregions of Minas Gerais state. This study highlights the challenges posed by emerging infectious diseases. It emphasizes the importance of epidemiological surveillance and accurate diagnosis in enabling timely responses for public health policies and appropriate medical care. IMPORTANCE: Brazil ranks second in the number of cases during the global monkeypox epidemic. The study, conducted in Minas Gerais, the second most populous state in Brazil with over 20 million inhabitants, utilized differential diagnostics, revealing a significant number of positive cases for other exanthematous viruses and emphasizing the need for accurate diagnoses. During the study, we were able to assess the co-circulation of other viruses alongside monkeypox, including varicella-zoster virus, molluscum contagiosum virus, and other orthopoxviruses. The significance of the research is underscored by the concentration of positive cases in populous areas, highlighting the challenges posed by emerging infectious diseases. This demographic context further amplifies the importance of the research in guiding public health policies and medical interventions, given the substantial population at risk. The study not only addresses a global concern but also holds critical implications for a state with such a large population and geographic expanse within Brazil. Overall, the study emphasizes the pivotal role of surveillance and precise diagnosis in guiding effective public health responses and ensuring appropriate medical interventions.


Sujet(s)
Épidémies de maladies , Humains , Brésil/épidémiologie , Études rétrospectives , Mâle , Femelle , Adulte , Diagnostic différentiel , Enfant , Adolescent , Orthopoxvirose simienne/diagnostic , Orthopoxvirose simienne/épidémiologie , Orthopoxvirose simienne/virologie , Jeune adulte , Enfant d'âge préscolaire , Adulte d'âge moyen , Virus de la variole simienne/génétique , Virus de la variole simienne/isolement et purification , Herpèsvirus humain de type 3/génétique , Herpèsvirus humain de type 3/isolement et purification , Nourrisson , Sujet âgé , Exanthème/virologie , Exanthème/épidémiologie , Réaction de polymérisation en chaine en temps réel
2.
Braz J Microbiol ; 55(1): 125-132, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-38052769

RÉSUMÉ

Varicella-zoster virus (VZV), a member of the Alphaherpesvirinae subfamily, causes varicella in primary infections and establishing a latent stage in sensory ganglia. Upon reactivation, VZV causes herpes zoster with severe neuralgia, especially in elderly patients. The mutation rate for VZV is comparatively lower than the other members of other alpha herpesviruses. Due to geographic isolation, different genotypes of VZV are circulating on separate continents. Here, we successfully isolated a VZV from the vesicular fluid of a youth zoster patient. Based on the single-nucleotide polymorphism profiles of different open reading frames that define the genotype, this newly isolated VZV primarily represents genotype clade 2 but also has characteristics of genotype clade 1. The next-generation sequencing provided a nearly full-length sequence, and further phylogenetic analysis revealed that this VZV isolate is distinct from clades 1 and 2. The Recombination Detection Program indicates that a possible recombinant event may occur between the VZV isolate and clade 1. In summary, we found that there is a circulating VZV isolate in China that may represent a recombinant between clade 1 and clade 2, providing new concerns that need to be considered in the future VZV vaccination program.


Sujet(s)
Zona , Herpèsvirus humain de type 3 , Adolescent , Humains , Sujet âgé , Herpèsvirus humain de type 3/génétique , Phylogenèse , Polymorphisme de nucléotide simple , Chine , Recombinaison génétique , Génomique
3.
Med. UIS ; 36(2)ago. 2023.
Article de Espagnol | LILACS | ID: biblio-1534840

RÉSUMÉ

El Síndrome de Ramsay Hunt es una entidad infrecuente, con una incidencia de 5 por cada 100.000 personas por año. Esta condición se caracteriza por una reactivación del virus de la varicela-zoster en el nervio facial. Su diagnóstico implica un reto para el médico puesto que suele ser netamente clínico, con la aparición de una triada consistente en: otalgia, parálisis facial ipsilateral y vesículas en el canal auditivo. El objetivo del artículo es presentar el caso de una mujer de 49 años de edad, con antecedente de epilepsia en tratamiento anticonvulsivante, quien ingresa con la triada clínica antes descrita, asociada a visión borrosa derecha y vértigo. La paciente fue tratada con antivirales y corticoides orales, presentando una resolución clínica favorable dado una reducción de más del 50% de las lesiones cutáneas. No se identificaron diferencias respecto a la presentación clínica de este síndrome al compararse con pacientes no epilépticos.


Ramsay Hunt Syndrome is a rare entity, with an incidence of 5 per 100,000 people per year. This condition is characterized by a reactivation of the varicella-zoster virus in the facial nerve. Its diagnosis implies a challenge for the physician since it is usually a clinical diagnosis, with the appearance of a clinical triad consisting of: otalgia, ipsilateral facial paralysis and vesicles in the ear canal. The objective of the article is to present the case of a 49-year-old woman, with a history of epilepsy receiving anticonvulsant treatment, who was admitted with the aforementioned clinical triad, associated with blurred right vision and vertigo. The patient was treated with oral antiviral management and oral corticosteroids, presenting a favorable clinical resolution given a reduction of more than 50% of the skin lesions. No differences were identified regarding the clinical presentation of this syndrome when compared with non-epileptic patients.


Sujet(s)
Humains , Femelle , Adulte d'âge moyen , Zona auriculaire , Paralysie faciale , Infection à virus varicelle-zona , Herpèsvirus humain de type 3 , Épilepsie , Zona
4.
Curr Res Microb Sci ; 4: 100192, 2023.
Article de Anglais | MEDLINE | ID: mdl-37273578

RÉSUMÉ

Human herpesviruses are enveloped viruses with double-stranded linear DNA genomes highly prevalent in the human population. These viruses are subdivided into three subfamilies, namely alphaherpesvirinae (herpes simplex virus type 1, HSV-1; herpes simplex virus type 2, HSV-2; and varicella-zoster virus, VZV), betaherpesvirinae (human cytomegalovirus, HCMV; human herpesvirus 6, HHV-6; and human herpesvirus 7, HHV-7) and gammaherpesvirinae (Epstein-Barr virus, EBV; and Kaposi's sarcoma-associated herpesvirus, KSHV). Besides encoding numerous molecular determinants to evade the host antiviral responses, these viruses also modulate cellular metabolic processes to promote their replication. Here, we review and discuss existing studies describing an interplay between carbohydrate metabolism and the replication cycle of herpesviruses, altogether highlighting potentially new molecular targets based on these interactions that could be used to block herpesvirus infections.

5.
J Pers Med ; 13(4)2023 Apr 11.
Article de Anglais | MEDLINE | ID: mdl-37109039

RÉSUMÉ

BACKGROUND: Chronic post-herpetic neuralgia (CPHN) is a symptomatic condition that afflicts adults and elderly individuals. The chronicity of this symptomatology can be conditioned by the epigenetic modifications induced by the virus on the processes of neurotransmission and sensitivity to pain. The aim of this study is to investigate whether manipulating endogenous bioelectrical activity (EBA), responsible for neurotransmission processes and contributing to the induction of epigenetic modifications, can alleviate pain symptoms. METHODS: This manipulation was carried out with the antalgic neuromodulation (ANM) treatment of radioelectric asymmetric conveyer (REAC) technology. Pain assessment before and after treatment was performed using a numerical analog scale (NAS) and a simple descriptive scale (SDS). RESULTS: The results of the analysis showed an over four-point decrease in NAS scale score and over one point decrease in SDS scale score, with a statistical significance for both tests of p < 0.005. CONCLUSIONS: The results obtained in this study demonstrate how REAC ANM manipulation of EBA can lead to improvement in epigenetically conditioned symptoms such as CPHN. These results should prompt further research to expand knowledge and ensure optimized therapeutic outcomes.

6.
J. Health Biol. Sci. (Online) ; 10(1): 1-9, 01/jan./2022. ilus, tab, graf
Article de Anglais | LILACS | ID: biblio-1378522

RÉSUMÉ

Objective: the aim of this study was to relate sociodemographic, epidemiological and clinical conditions to the occurrence of severe cases of HZ in reference hospital of Fortaleza. Methods: this is a cross-sectional analytical study, based on medical records of patients admitted from 2009 to 2018. Pearson's x2 test or Fisher's exact test were used when appropriate. Results: we analyzed 196 medical records. The presence of complications occurred in 69.9%, the most affected region was the cranial (68.9%), and 1.5% died. The presence of vesicles (PR=1.37; 95%CI: 1.03-1.82; p=0.01) and the choice of antibiotic associated antiviral therapy (PR=0.58; 95%CI: 0.46-0.73; p=0.00) were significantly associated with the severity. Conclusions: the disease may be more severe at ages over 50. The presence of lesions in vesicles was associated with a higher prevalence of complications and the use of antibiotics and antivirals as a protective factor.


Objetivo: relacionar condições sociodemográficas, epidemiológicas e clínicas à ocorrência de casos graves de HZ em hospital de referência de Fortaleza. Métodos: trata-se de um estudo analítico transversal, baseado em prontuários de pacientes internados de 2009 a 2018. Foram utilizados o teste x2 de Pearson ou o teste exato de Fisher, quando apropriado. Resultados: foram analisados 196 prontuários. A presença de complicações ocorreu em 69,9%, a região mais acometida foi a craniana (68,9%), e 1,5% foi a óbito. A presença de vesículas (RP=1,37; IC95%: 1,03-1,82; p=0,01) e a escolha da terapia antiviral associada a antibióticos (RP=0,58; IC95%: 0,46-0,73; p=0,00) foram significativamente associadas com a gravidade. Conclusões: a doença pode ser mais grave a partir dos 50 anos. A presença de lesões em vesículas foi associada à maior prevalência de complicações e o uso de antibióticos e antivirais como fator de proteção.


Sujet(s)
Zona , Dossiers médicaux , Maladie , Épidémiologie , Herpèsvirus humain de type 3 , Hospitalisation , Patients hospitalisés , Méthodes
7.
Rev. cuba. med. trop ; 74(3)dic. 2022.
Article de Espagnol | LILACS, CUMED | ID: biblio-1449987

RÉSUMÉ

Introducción: Una de las complicaciones de la reactivación del virus de la varicela-zóster es el compromiso de los nervios craneales; sin embargo, es inusual que se presente como una oftalmoplejía completa. Objetivo: Describir el caso de un adulto inmunocompetente que desarrolló una oftalmoplejía infecciosa por reactivación del virus de la varicela-zóster. Caso clínico: El paciente presentó alteración completa de la motilidad de los músculos extraoculares del ojo izquierdo con compromiso del reflejo pupilar, disminución en la agudeza visual y neuralgia trigeminal concomitante; no tuvo signos o síntomas sugestivos de encefalitis o meningitis. Días antes de la oftalmoplejía aparecieron vesículas en la región frontal y periorbitaria izquierdas. Mediante el estudio del líquido cefalorraquídeo (LCR) con panel para meningitis/encefalitis FilmArray® se documentó positividad solo para el virus de la varicela-zóster. El paciente fue tratado con aciclovir, esteroides y neuromoduladores, con lo cual obtuvo mejoría parcial de sus síntomas a las dos semanas. La discusión se realizó a partir de los pocos reportes de casos encontrados en diferentes bases de datos. Conclusiones: Este caso amplía el entendimiento clínico y terapéutico de una manifestación inusual de esta enfermedad frecuente, que combina un compromiso patológico de varios nervios craneales por la reactivación del virus de la varicela-zóster.


Introduction: Cranial nerve involvement is one of the complications of varicella-zoster virus reactivation; however, presenting complete ophthalmoplegia is unusual. Objective: To describe the case of an immunocompetent adult who developed an infectious ophthalmoplegia due to varicella-zoster virus reactivation. Clinical case: The patient presented complete alteration of the extraocular muscle motility of the left eye with pupillary reflex compromise, decrease in visual acuity and concomitant trigeminal neuralgia. The patient did not present signs or symptoms suggestive of encephalitis or meningitis. Days before the ophthalmoplegia, vesicles appeared in the left frontal and periorbital regions. Cerebrospinal fluid (CSF) examination with FilmArray® meningitis/encephalitis panel documented positivity for varicella-zoster virus only. The patient was treated with acyclovir, steroids and neuromodulators, resulting in partial improvement of his symptoms after two weeks. The discussion was based on the few case reports found in different databases. Conclusions: This case broadens the clinical and therapeutic understanding of an unusual manifestation of this common disease, which combines pathologic involvement of several cranial nerves due to varicella-zoster virus reactivation.


Sujet(s)
Humains
8.
Rev. baiana saúde pública ; 46(Supl. Especial 1): 48-55, 20221214.
Article de Portugais | LILACS | ID: biblio-1415162

RÉSUMÉ

O vírus varicela-zóster pode recorrer diante de imunodeficiência. A falta de imunidade celular pode ser tão grave a ponto de comprometer o sistema nervoso central. Neste caso, o paciente apresentou quadro de aids com meningoencefalopatia por vasculite. Pela alta suspeição diagnóstica, foi iniciado tratamento, empírica e precocemente, com aciclovir, corticoide e anticonvulsivante endovenosos. O diagnóstico se deu posteriormente. Com base neste caso, foi proposta uma estratégia eficaz de atendimento.


Varicella zoster virus infection may recur in the face of immunodeficiency, which can be so severe as to compromise the central nervous system. In the case studied, the patient presented a clinical picture of AIDS along with vasculitis meningoencephalopathy. Due to high diagnostic suspicion, intravenous Acyclovir, Corticosteroid and Intravenous Anticonvulsant were administered early. Diagnosis occurred later. On this case, an effective care strategy was proposed.


El virus de la varicela zóster puede reaparecer ante una inmunodeficiencia. La falta de inmunidad celular puede ser tan grave como para comprometer el sistema nervioso central. En este caso, el paciente desarrolló SIDA junto con meningoencefalopatía por vasculitis. Debido a la alta sospecha diagnóstica, se inició de forma empírica y precoz Aciclovir, corticoides y anticonvulsivantes intravenosos. Después, se realizó el diagnóstico. A partir de este caso se planteó una estrategia de atención eficaz.


Sujet(s)
Humains
10.
An. bras. dermatol ; An. bras. dermatol;97(4): 467-470, July-Aug. 2022. graf
Article de Anglais | LILACS-Express | LILACS | ID: biblio-1383620

RÉSUMÉ

Abstract Wolf's isotopic phenomenon occurs when a new dermatosis appears on a site that has already healed from a previous dermatological disease of another etiology. This report describes the case of a 44-year-old female patient undergoing treatment for breast carcinoma who recently had brownish erythematous lesions appearing on the scar region of previous herpes zoster on the right hemithorax. Histopathology and immunohistochemistry examination confirmed skin metastasis of breast cancer. Herpes zoster scars require attention due to the possibility of an isotopic response as a facilitating factor in some dermatoses, sometimes severe ones, such as neoplasms.

11.
An Bras Dermatol ; 97(4): 467-470, 2022.
Article de Anglais | MEDLINE | ID: mdl-35676106

RÉSUMÉ

Wolf's isotopic phenomenon occurs when a new dermatosis appears on a site that has already healed from a previous dermatological disease of another etiology. This report describes the case of a 44-year-old female patient undergoing treatment for breast carcinoma who recently had brownish erythematous lesions appearing on the scar region of previous herpes zoster on the right hemithorax. Histopathology and immunohistochemistry examination confirmed skin metastasis of breast cancer. Herpes zoster scars require attention due to the possibility of an isotopic response as a facilitating factor in some dermatoses, sometimes severe ones, such as neoplasms.


Sujet(s)
Tumeurs du sein , Carcinomes , Zona , Seconde tumeur primitive , Tumeurs cutanées , Cicatrice/anatomopathologie , Femelle , Zona/anatomopathologie , Herpèsvirus humain de type 3 , Humains , Mélanome , Melanoma, Cutaneous Malignant
12.
Acta neurol. colomb ; 38(1): 45-50, ene.-mar. 2022. tab, graf
Article de Espagnol | LILACS | ID: biblio-1374130

RÉSUMÉ

RESUMEN La meningoencefalitis por el VZV es una patología poco frecuente que se presenta con la reactivación del virus dentro del organismo. OBJETIVO: Describir la presentación clínica de dos pacientes con neuroinfección por VZV posteriormente a infección por SARS-CoV-2. REPORTE DEL CASO: El primer caso corresponde a un hombre de 59 años con antecedente de neumonía moderada por SARS-CoV-2 que después cursó con meningoencefalitis por VZV y, además, desarrolló un síndrome de Ramsay Hunt. El segundo caso es el de una mujer de 37 años con antecedente de infección leve por SARS CoV-2 con un cuadro de cefalea con signos de alarma, en quien se documentó neuroinfección por VZV


ABSTRACT Meningoencephalitis caused by varicella zoster virus is a rare pathology that presents due to the reactivation of the virus in the organism OBJECTIVE: To describe the clinical presentation of two patients with VZV neuroinfection presented after a SARS CoV-2 infection. CASE REPORT: The first case is a 59 year old male with previous moderate SARS CoV-2 infection who presented meningoencephalitis and was diagnosed with Ramsay Hunt's Syndrome. The second case is a 37 year old female with previous SARS CoV-2 infection who presented with an acute onset headache and was documented with VZV neuroinfection.


Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Encéphalite zostérienne/virologie , COVID-19/complications , Antiviraux/usage thérapeutique , Aciclovir/usage thérapeutique , Encéphalite zostérienne/diagnostic , Encéphalite zostérienne/traitement médicamenteux
13.
J Laryngol Otol ; 136(10): 975-978, 2022 Oct.
Article de Anglais | MEDLINE | ID: mdl-35075988

RÉSUMÉ

OBJECTIVE: Herpes zoster virus can cause inflammatory neuropathy of the facial nerve. However, studies evaluating the prevalence of this agent in peripheral facial palsy are heterogeneous regarding sample group selection, laboratory analysis method and variables studied. In addition, there are a lack of epidemiological data in the Brazilian population on this serological phenomenon in peripheral facial palsy. This study estimated herpes zoster reactivation prevalence in serological samples through chemiluminescence immunoassay for quantitative determination of specific antibodies directed against the virus. METHODS: This cross-sectional study sought to determine the prevalence of viral reactivation by herpes zoster in subjects with idiopathic peripheral facial palsy through analysis of serological samples over a year. RESULTS: Forty-seven patients (32 females and 15 males) participated. Severe paralysis was more common in older patients (p = 0.017). Facial pain (p = 0.02) and vertigo (p = 0.001) were related to a worse evolution of facial palsy. The rate of serological reactivation of the virus was 12.76 per cent. CONCLUSION: The rate of serological reactivation of herpes virus in idiopathic peripheral facial palsy in our population is similar to foreign literature data, suggesting similar aetiological mechanisms in the genesis of this morbidity.


Sujet(s)
Paralysie faciale de Bell , Paralysie faciale , Zona , Sujet âgé , Anticorps antiviraux , Paralysie faciale de Bell/épidémiologie , Études transversales , Paralysie faciale/épidémiologie , Femelle , Zona/complications , Zona/diagnostic , Zona/épidémiologie , Herpèsvirus humain de type 3/physiologie , Humains , Mâle , Prévalence
14.
Vaccine ; 40(2): 390-395, 2022 01 21.
Article de Anglais | MEDLINE | ID: mdl-34507860

RÉSUMÉ

INTRODUCTION: The varicella vaccine was first introduced into the Brazilian immunization schedule in September 2013 as a single dose for children aged 15 months. In 2018, a second dose was recommended for individuals between 4 and 6 years old. This study aims to assess the impact of routine varicella vaccination on the number and profile of hospitalized varicella patients during the single dose period, as well as in the first two years after the adoption of the second dose. METHODS: An observational retrospective study was conducted in an infectious disease pediatric hospital, in Minas Gerais, Brazil. Clinical as well as epidemiological data from patients hospitalized due to varicella between 2010 and 2019 were collected. Patients were split into groups based on the vaccine introduction: pre-vaccine period, single dose and two-dose period. They were compared by age, sex, reason for admission, illness-related complications and clinical outcome. RESULTS: There were 1193 admissions due to varicella during the studied period. When compared with the pre-vaccine period, the number of hospitalizations decreased in 61.5% during the single-dose regime, reaching 95.2% in the two-dose period. Hospitalization rates decreased in all age groups, including non-vaccinated individuals such as those younger than 12 months (92.1%). As for reasons of admission, secondary bacterial skin infections were perceived to be the most common cause (>70%). A reduction was also seen in admission of immunocompromised or HIV positive patients (84.8%). CONCLUSION: The collected data shows a significant impact in the number of hospital admissions due to varicella after six years of the implementation of the vaccine, positively affecting both vaccinated and non-vaccinated individuals. Further reduction was seen after the second dose was initiated, but its true impact will only be understood fully after a longer period of continuous vaccination.


Sujet(s)
Varicelle , Brésil/épidémiologie , Varicelle/épidémiologie , Varicelle/prévention et contrôle , Vaccin contre la varicelle , Enfant , Enfant d'âge préscolaire , Hospitalisation , Humains , Nourrisson , Études rétrospectives , Vaccination
15.
Rev. chil. infectol ; Rev. chil. infectol;38(3): 446-451, jun. 2021. ilus, tab, graf
Article de Espagnol | LILACS | ID: biblio-1388251

RÉSUMÉ

Resumen Presentamos el caso de un varón de 63 años, inmunocompetente, con una necrosis retinal aguda (NRA) unilateral. Consultó por visión borrosa, dolor ocular, fotofobia y cefalea. Se confirmó una papilitis y coriorretinitis periférica asociada a vasculitis e isquemia retinal periférica. El estudio molecular por RPC de humor acuoso detectó la presencia de virus varicela zoster. El paciente fue tratado con terapia combinada con corticoesteroides orales, aciclovir oral/intravenoso, ganciclovir intravítreo semanal y luego valaciclovir oral por tres meses. Se demostró una disminución progresiva de la carga viral en el humor acuoso durante el tratamiento. El seguimiento mostró una mejoría del cuadro inflamatorio y una leve recuperación de la agudeza visual, sin embargo, finalmente presentó un desprendimiento de retina con pérdida casi total de la visión unilateral. La NRA es una complicación infrecuente provocada por algunos virus herpes con mal pronóstico visual, desenlace que puede ser mejorado con un diagnóstico y tratamiento precoz con antivirales. El tratamiento prolongado permite evitar la recaída y el compromiso contralateral.


Abstract We present the case of a 63-year-old immunocompetent man with unilateral acute retinal necrosis (ARN). He consulted for blurred vision, eye pain, photophobia, and headache. Papillitis and peripheal chorioretinitis associated with vasculitis and peripheral retinal ischemia was confirmed. PCR from aqueous humor sample detected varicella zoster virus. The patient was treated with a combined therapy of oral corticosteroids, oral / intravenous acyclovir along with weekly intravitreous ganciclovir doses followed by oral valaciclovir for three months. A progressive decrease in viral load in aqueous humor was demonstrated during treatment. Follow-up showed improvement in the inflammatory condition and a slight recovery of visual acuity, however, finally he presented a retinal detachment with total loss of one-sided vision. ARN is an uncommon complication caused by some herpesviruses with a poor visual prognosis, an outcome that can be improved with early diagnosis and treatment using appropriate antivirals. Prolonged treatment reduces relapse frequency and fellow eye compromise.


Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Syndrome de nécrose rétinienne aigüe/diagnostic , Syndrome de nécrose rétinienne aigüe/traitement médicamenteux , Herpèsvirus humain de type 3/génétique , Antiviraux/usage thérapeutique , Aciclovir/usage thérapeutique , Réaction de polymérisation en chaîne , Études de suivi
16.
Acta neurol. colomb ; 37(1,supl.1): 1-12, mayo 2021. tab, graf
Article de Espagnol | LILACS | ID: biblio-1248574

RÉSUMÉ

RESUMEN El espectro de manifestaciones neurológicas secundarias a la infección por la familia de virus Herpesviridae es heterogénea, depende de factores ambientales, de la susceptibilidad inmunológica del huésped (infección de por vida) y la susceptibilidad genética, entre otras variables. Así, el compromiso puede ser fatal en ausencia de un rápido diagnóstico y tratamiento. El objetivo de revisar la neuroinfección por herpesvirus tipo 1 (HSV-1), tipo 2 (HSV-2) y virus de la varicela zóster (VVZ) es profundizar en aquellas manifestaciones clínicas que generan compromiso del sistema nervioso central y periférico, así como contribuir a una detección y confirmación temprana de la infección, establecer un enfoque terapéutico adecuado, que depende del compromiso clínico, y, finalmente, minimizar las complicaciones y secuelas neurológicas a largo plazo.


SUMMARY The spectrum of neurological manifestations secondary to infection by the family of viruses Herpesviridae is heterogeneous depending on environmental factors, susceptibility host immunological (infection for life), genetic susceptibility among other variables. Thus, the compromise can be fatal in the absence of prompt diagnosis and treatment. He objective of reviewing neuroinfection by Herpes virus type 1 (HSV-1), type 2 (HSV-2) and virus varicella zoster (VVZ) is to delve into those clinical manifestations that generate central and peripheral nervous system involvement, seeks to detect and confirm early, and likewise establish an adequate therapeutic approach that depends on the clinical commitment, ultimately minimizing long-term neurological complications and sequelae term.


Sujet(s)
Développement orienté du transit
17.
J Neurovirol ; 27(3): 397-402, 2021 Jun.
Article de Anglais | MEDLINE | ID: mdl-33830465

RÉSUMÉ

The frequency of central nervous system infections due to herpesvirus have been studied in various populations; however, studies in Mexican mestizo patients are scant. This paper documents the frequency of herpesvirus encephalitis in Mexican mestizo patients from the National Institute of Neurology and Neurosurgery (NINN) of Mexico. To study the frequency of herpetic viral encephalitis at the NINN in the period from 2004 to 2009. We reviewed clinical records from patients with clinically suspected encephalitis; polymerase chain reaction assays were done for detection of herpesviruses in cerebrospinal fluid (CSF) samples. The total number of patients studied was 502; in 59 (12%), the diagnosis of herpetic encephalitis was confirmed by PCR-based testing of CSF. Of them, 21 (36%) were positive for herpes simplex virus type 1, 15 (25%) for Epstein-Barr virus, 10 (17%) for varicella zoster virus, 8 (14%) for cytomegalovirus, 3 (5%) for human herpesvirus 6, and 2 (3%) for herpes simplex virus 2. Our results show a varied frequency of viral encephalitis in mestizo patients due to herpesviruses in a tertiary neurological center and point out the importance of modern molecular technology to reach the etiological diagnosis in cases of encephalitis.


Sujet(s)
Infections à cytomégalovirus/diagnostic , Encéphalite zostérienne/diagnostic , Encéphalite virale/diagnostic , Infections à virus Epstein-Barr/diagnostic , Herpès génital/diagnostic , Herpès/diagnostic , Infections à roséolovirus/diagnostic , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Études transversales , Cytomegalovirus/génétique , Cytomegalovirus/pathogénicité , Infections à cytomégalovirus/épidémiologie , Infections à cytomégalovirus/ethnologie , Infections à cytomégalovirus/virologie , Encéphalite zostérienne/épidémiologie , Encéphalite zostérienne/ethnologie , Encéphalite zostérienne/virologie , Encéphalite virale/épidémiologie , Encéphalite virale/ethnologie , Encéphalite virale/virologie , Infections à virus Epstein-Barr/épidémiologie , Infections à virus Epstein-Barr/ethnologie , Infections à virus Epstein-Barr/virologie , Ethnies , Femelle , Herpès génital/épidémiologie , Herpès génital/ethnologie , Herpès génital/virologie , Herpès/épidémiologie , Herpès/ethnologie , Herpès/virologie , Herpèsvirus humain de type 1/génétique , Herpèsvirus humain de type 1/pathogénicité , Herpèsvirus humain de type 2/génétique , Herpèsvirus humain de type 2/pathogénicité , Herpèsvirus humain de type 3/génétique , Herpèsvirus humain de type 3/pathogénicité , Herpèsvirus humain de type 4/génétique , Herpèsvirus humain de type 4/pathogénicité , Herpèsvirus humain de type 6/génétique , Herpèsvirus humain de type 6/pathogénicité , Humains , Incidence , Mâle , Mexique/épidémiologie , Adulte d'âge moyen , Réaction de polymérisation en chaîne/méthodes , Études rétrospectives , Infections à roséolovirus/épidémiologie , Infections à roséolovirus/ethnologie , Infections à roséolovirus/virologie
18.
Med. UIS ; 34(1): 91-99, ene.-abr. 2021. tab, graf
Article de Espagnol | LILACS | ID: biblio-1360588

RÉSUMÉ

Resumen Un cuadro de meningitis aséptica, en el contexto de un paciente inmunosuprimido con diagnóstico de infección por Virus de Inmunodeficiencia Humana (VIH), debe llevar a pensar en múltiples diagnósticos diferenciales. Entre estos, se incluye el virus varicela zóster (VVZ) como uno de los principales agentes causales de meningitis a líquido cefalorraquídeo claro. Su reactivación da lugar a múltiples manifestaciones neurológicas potencialmente mortales en las que se consideraba al rash vesicular, o exantema pápulo/vesículo/ costroso como un signo fundamental para su diagnóstico. No obstante, las lesiones cutáneas están ausentes en más de un tercio de los pacientes con compromiso del sistema nervioso central. A continuación, se presenta el caso de un paciente con infección por VIH que presenta cefalea más fiebre, con hallazgos en líquido cefalorraquídeo de pleocitosis neutrofílica y una prueba molecular confirmatoria para virus varicela zóster, en ausencia de rash vesicular previo que guiara hacia este diagnóstico. MÉD.UIS.2021;34(1): 91-9.


Abstract The clinical presentation of aseptic meningitis in the context of an immunosuppressed patient with a diagnosis of Human Immunodeficiency Virus (HIV) infection, should lead us to consider multiple differential diagnoses. Among these, the Varicella Zoster Virus (VZV) has been found as one of the main causative agents of clear cerebrospinal fluid meningitis. Its reactivation gives rise to multiple life-threatening neurological manifestations in which vesicular rash, or papule / vesicular / crusted rash was considered a fundamental sign for its diagnosis. However, skin lesions are absent in more than a third of patients with central nervous system involvement. Herein, we report a case of an HIV-infected patient with headache, fever and neutrophilic pleocytosis with FilmArray that confirms Varicella Zoster virus infection in an immunocompromised patient in the absence of vesicular rash. MÉD.UIS.2021;34(1): 91-9.


Sujet(s)
Humains , Mâle , Adulte , Méningite aseptique , Sérodiagnostic du SIDA
19.
Article de Anglais, Portugais | LILACS, Sec. Est. Saúde SP | ID: biblio-1136794

RÉSUMÉ

ABSTRACT Objective: To assess the number of cases and the profile of hospitalizations from varicella after the introduction of the measles, mumps, rubella and varicella combination vaccine in the public health system. Methods: Retrospective study in an infectious diseases pediatric hospital of reference in Southeast Brazil. The cases with a clinical diagnosis of varicella, from January 2011 to June 2016, were assessed from pediatricians' medical records. The hospitalizations were classified into a pre-vaccine group and post-vaccine group, based on the date the vaccine was introduced (September 2013). Both groups were compared by age, sex, time of hospitalization, reason for hospitalization, hospital complications, duration of intensive care, and clinical outcome. Results: A total of 830 hospitalizations were recorded; 543 in the pre-vaccine period and 287 in the post-vaccine period, a reduction of 47.1% (p<0.001). In both periods, a similar profile in the hospitalizations was noticed: majority male; aged between one to five years old; most complications due to secondary causes (mainly skin infections); main outcome was clinical improvement and discharge from the hospital. In the pre-vaccine period, six deaths were recorded and two were recorded in the post-vaccine period. Conclusions: The profile of the hospitalizations was expected to stay the same since this study did not compare vaccinated with unvaccinated children, but hospitalizations before and after the vaccine was introduced. In accordance with the medical literature, we found a significant fall in the number of hospitalizations from varicella.


RESUMO Objetivo: Avaliar o número de casos e o perfil das internações por varicela após a introdução da vacina quádrupla viral na rede pública. Métodos: Estudo retrospectivo conduzido em hospital pediátrico referência em doenças infectocontagiosas na Região Sudeste do Brasil. Foram avaliados os casos com diagnóstico clínico de varicela, registrados em prontuário por médico pediatra, de janeiro de 2011 até junho de 2016. As internações foram classificadas em grupo pré-vacinal e grupo pós-vacinal, com base na data de introdução da vacina (setembro de 2013). Os grupos foram comparados em relação a: faixa etária, sexo, tempo de hospitalização, causas da internação, complicações hospitalares, tempo da internação em terapia intensiva e desfecho clínico. Resultados: Foram documentadas 830 internações, 543 no período pré-vacinal e 287 no pós-vacinal, ocorrendo redução de 47,1% nas internações (p<0,001). Em ambos os períodos, notou-se um perfil similar das internações, predominantemente: sexo masculino; faixa etária de um a cinco anos; por causas secundárias (principalmente infecções de pele); evoluindo com melhora clínica e alta hospitalar. Em relação ao número de óbitos, ocorreram seis no período pré-vacinal e dois no pós-vacinal. Conclusões: A manutenção do perfil das internações era esperada, visto que o trabalho não comparou crianças vacinadas com não vacinadas, e sim internações pré e pós-vacinais. Observou-se, em concordância com a literatura, queda substancial no número de internações por varicela.


Sujet(s)
Humains , Mâle , Femelle , Nourrisson , Enfant d'âge préscolaire , Enfant , Varicelle/épidémiologie , Vaccin contre la varicelle/administration et posologie , Durée du séjour/statistiques et données numériques , Brésil/épidémiologie , Études rétrospectives , Vaccination , Vaccins combinés , Vaccin contre la rougeole, les oreillons et la rubéole
20.
Virology ; 549: 85-88, 2020 10.
Article de Anglais | MEDLINE | ID: mdl-32858308

RÉSUMÉ

Bell's Palsy is the most frequent acute neuropathy of cranial nerves; it has been associated in various reports to herpes viruses. In a prospective study we searched the presence of DNA from five herpes viruses (HSV-1 and 2, VZV, EBV and HHV-6) in 79 patients at the acute phase of Bell's Palsy. Results were related with various parameters; age, gender and clinical outcome. We found the significant presence (p˂0.001) of HSV-1 and VZV in 39% and 42% of patients. However, a large percentage of cases were negative. When comparisons were made between subgroups according to gender and age no differences were found with viral findings nor with clinical outcome of palsy, which was of clinical remission in most cases (78%). Our results suggest that herpes viruses might participate in the complex mechanisms of autoimmunity of Bell's Palsy but not as determinant etiological element.


Sujet(s)
Hormones corticosurrénaliennes/usage thérapeutique , Antiviraux/usage thérapeutique , Paralysie faciale de Bell/traitement médicamenteux , Herpèsvirus humain de type 1/génétique , Herpèsvirus humain de type 3/génétique , Aciclovir/usage thérapeutique , Adolescent , Adulte , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Anticorps antiviraux/sang , Auto-immunité , Paralysie faciale de Bell/immunologie , Paralysie faciale de Bell/anatomopathologie , Paralysie faciale de Bell/virologie , Études cas-témoins , ADN viral/sang , ADN viral/génétique , Nerf facial/effets des médicaments et des substances chimiques , Nerf facial/immunologie , Nerf facial/anatomopathologie , Nerf facial/virologie , Femelle , Herpèsvirus humain de type 1/pathogénicité , Herpèsvirus humain de type 2/génétique , Herpèsvirus humain de type 3/pathogénicité , Herpèsvirus humain de type 4/génétique , Herpèsvirus humain de type 6/génétique , Humains , Immunoglobuline G/sang , Mâle , Adulte d'âge moyen , Études prospectives , Induction de rémission , Facteurs sexuels , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE